Clinical trial
Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage
NCT04890379 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 1, 2021
- Completion date
- December 31, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage